Pharma

Pharma·

AbbVie Eyes $10.9 Billion Acquisition to Bolster Eczema Treatment Portfolio

US00287Y1091US00287Y1091
US00287Y1091
Pharma·

Onco-Innovations Limited: Successful Scaling of the Pharmaceutical Active Ingredient A83B4C63 and Appointment of a New CFO

CA68237C1059CA68237C1059
CA68237C1059
Pharma·

Lawmakers Mobilize Against Loneliness Crisis: A New Frontier for Public Health Spending

Pharma·

US Government Investigates Drug Prices in Germany: A Warning Signal for the Pharmaceutical Industry

US5324571083US5324571083US7170811035US7170811035
US5324571083
Pharma·

Novo Nordisk: Challenges and Opportunities in Focus for Investors

DK0060534915DK0060534915
DK0060534915
Pharma·

Shortage of Skilled Workers in Speech Therapy: Reforms Urgently Needed

Pharma·

Midjourney's Ambitious Leap into Healthcare: Can AI Transform Medical Imaging?

Pharma·

Digitalization in Healthcare: Increasing Efficiency Through Electronic Referrals and Appointment Exchanges

Pharma·

Statutory Health Insurers Demand Stronger Patient Rights for Self-Payment Services

Pharma·

Onco-Innovations Successfully Completes Project with Kuano and Optimizes PNKP Inhibitor Technology

CA68237C1059CA68237C1059
CA68237C1059
Pharma·

Decline in Inpatient Treatments for Sleep Disorders: A Sign of Progress in Healthcare

Pharma·

BioNxt Solutions Inc. Focuses on Strategic Partnerships for Marketing BNT23001

CA0909741062CA0909741062
CA0909741062
Pharma·

Expanded Services in Pharmacies: A Step in the Right Direction

Pharma·

Expanded Services for Pharmacies: A Step Towards Health Innovation

Pharma·

Vidac Pharma Holding PLC: Recruitment in Phase 2B Study with VDA-1102 Successfully Completed

GB00BM9XQ619GB00BM9XQ619
GB00BM9XQ619
Pharma·

Redwood AI Corp. Launches Disease Monitoring Initiative in Central Africa

CA7579221093CA7579221093
CA7579221093
Pharma·

Growth in the Healthcare Sector: Staffing Increase in German Health Authorities by 2025

Pharma·

Growing Need for Action: WHO Calls for Better Heat Protection in Europe

Pharma·

Science Ministries Warn of Risks of the Contribution Stabilization Act for University Hospitals

Pharma·

Onco-Innovations Starts Process Development for Innovative PNKP Inhibitor Technology

CA68237C1059CA68237C1059
CA68237C1059
Pharma·

Eli Lilly's Next-Gen Weight-Loss Drug Sparks Shareholder Optimism

US5324571083US5324571083
US5324571083
Pharma·

Zealand Pharma Faces Setback as Weight-Loss Drug Trial Sees High Discontinuation Rates

DK0060946788DK0060946788
DK0060946788
Pharma·

Pharmaceutical Industry Under Pressure: Challenges from New Discount Regulations

DE0005068404DE0005068404
DE0005068404
Pharma·

Wegovy Continues to Lead the GLP-1 Market Despite New Entrants

US5324571083US5324571083DK0060534915DK0060534915
US5324571083
Pharma·

Pharmaceutical Industry in Germany Under Pressure: Investment Cancellations as a Warning Signal

US5324571083US5324571083
US5324571083
Pharma·

Emerging Weight-Loss Therapies Poised to Outshine GLP-1s

Pharma·

American Doctor Successfully Treated for Ebola in Germany Amid Outbreak

Pharma·

Pharmaceutical Industry in Germany: Warning Signals from Canceled Investments

US5324571083US5324571083
US5324571083
Pharma·

Ebola Bundibugyo Strain: A Growing Threat to Global Health and Investment

Pharma·

Ebola Pioneer: Travel Bans Are Unnecessary